carbidopa has been researched along with Degenerative Diseases, Central Nervous System in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Cubo, E; Miranda, J | 1 |
| Alobaidi, A; Bao, Y; Chaudhuri, KR; Jalundhwala, YJ; Jones, G; Kandukuri, PL; Madin-Warburton, M; Najle-Rahim, S; Oddsdottir, J; Pickard, AS; Ridley, C; Schrag, A; Sus, J; Xu, W | 1 |
| Lezzi, P; Lezzi, T; Lupo, R; Vitale, E | 1 |
| Baróti, B; Constantin, V; Forró, T; Frigy, A; Kelemen, K; Metz, J; Mihály, I; Orbán-Kis, K; Szász, JA; Szász, RM; Szatmári, S; Török, Á | 1 |
| Liu, X; Ming, D; Moussian, B; Pang, M; Peng, R; Su, Y; Wang, P; Wang, Y; Zhu, Y | 1 |
| Jog, M; Kumar, N | 1 |
| Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H; Nardin, R; Saadia, D; Voustianiouk, A; Yahr, MD | 1 |
2 review(s) available for carbidopa and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
The Prephase Nursing in Levodopa Carbidopa Intestinal Gel Therapy.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Neurodegenerative Diseases; Parkinson Disease; Quality of Life | 2022 |
Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson's disease.
Topics: Aged; Biological Products; Carbidopa; Cholinergic Antagonists; Dopamine; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase; Neurodegenerative Diseases; Parkinson Disease | 2022 |
1 trial(s) available for carbidopa and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Carbidopa; Cross-Over Studies; Double-Blind Method; Droxidopa; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Neurodegenerative Diseases; Norepinephrine; Posture; Single-Blind Method; Treatment Outcome | 2003 |
4 other study(ies) available for carbidopa and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Spinocerebellar ataxia type 3: response to levodopa infusion in two cases.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Infusions, Parenteral; Levodopa; Machado-Joseph Disease; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders | 2022 |
The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England.
Topics: Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Drug Combinations; Gels; Humans; Levodopa; Neurodegenerative Diseases; Parkinson Disease; Quality of Life | 2022 |
Ten-year trends of the characteristics in patients with advanced Parkinson's disease at the time of intestinal gel therapy introduction
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesias; Gels; Humans; Levodopa; Male; Neurodegenerative Diseases; Parkinson Disease; Retrospective Studies | 2022 |
Fahr's Disease Presenting as Late-Onset Levodopa-Responsive Parkinsonism.
Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Calcinosis; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Neurodegenerative Diseases | 2017 |